Search results: Sage Journals

Free accessResearch articleFirst published December, 2015

Re-evaluation of ABTS•+ Assay for Total Antioxidant Capacity of Natural Products

Jian-Wei Dong, Le Cai, Yun Xing [...]

Natural Product Communications

Free accessReview articleFirst published October, 2016

The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia

Gilad Itchaki, Jennifer R. Brown

Therapeutic Advances in Hematology

Open accessResearch articleFirst published September 16, 2014

A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia 1

George M. Haig, Yili Pritchett, Andreas Meier [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published October, 2014

Caspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell lines

YongKu Ryu, Connor P Hall, C Patrick Reynolds [...]

Experimental Biology and Medicine

Free accessResearch articleFirst published August, 2012

ABT-737 Synergizes with Arsenic Trioxide to Induce Apoptosis of Gastric Carcinoma Cells In Vitro and In Vivo

Xp Sun, X Zhang, C He [...]

Journal of International Medical Research

Restricted accessResearch articleFirst published April 12, 2016

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized,Double-Blind,Placebo-Controlled Study

Hana Florian, Andreas Meier, Serge Gauthier [...]

Journal of Alzheimer’s Disease

Free accessOtherFirst published February, 2019

The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer

Hong Li, Huogang Wang, Ke Deng [...]

Cancer Biomarkers

Open accessResearch articleFirst published 2020

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published May, 1999

Policy Discourse and the 1982 ABT Pay TV Inquiry

Matthew Pearce

Media International Australia

Restricted accessResearch articleFirst published February, 2023

Navitoclax (ABT-263) Rejuvenates Human Skin by Eliminating Senescent Dermal Fibroblasts in a Mouse/Human Chimeric Model

Kento Takaya, Tatsuyuki Ishii, Toru Asou [...]

Rejuvenation Research

Free accessResearch articleFirst published December, 2015

Re-evaluation of ABTS•+ Assay for Total Antioxidant Capacity of Natural Products

Jian-Wei Dong, Le Cai, Yun Xing [...]

Natural Product Communications

Free accessReview articleFirst published October, 2016

The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia

Gilad Itchaki, Jennifer R. Brown

Therapeutic Advances in Hematology

Open accessResearch articleFirst published September 16, 2014

A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia 1

George M. Haig, Yili Pritchett, Andreas Meier [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published October, 2014

Caspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell lines

YongKu Ryu, Connor P Hall, C Patrick Reynolds [...]

Experimental Biology and Medicine

Free accessResearch articleFirst published August, 2012

ABT-737 Synergizes with Arsenic Trioxide to Induce Apoptosis of Gastric Carcinoma Cells In Vitro and In Vivo

Xp Sun, X Zhang, C He [...]

Journal of International Medical Research

Restricted accessResearch articleFirst published April 12, 2016

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized,Double-Blind,Placebo-Controlled Study

Hana Florian, Andreas Meier, Serge Gauthier [...]

Journal of Alzheimer’s Disease

Free accessOtherFirst published February, 2019

The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer

Hong Li, Huogang Wang, Ke Deng [...]

Cancer Biomarkers

Open accessResearch articleFirst published 2020

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published May, 1999

Policy Discourse and the 1982 ABT Pay TV Inquiry

Matthew Pearce

Media International Australia

Restricted accessResearch articleFirst published February, 2023

Navitoclax (ABT-263) Rejuvenates Human Skin by Eliminating Senescent Dermal Fibroblasts in a Mouse/Human Chimeric Model

Kento Takaya, Tatsuyuki Ishii, Toru Asou [...]

Rejuvenation Research